<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="TB4" orientation="portrait" position="float">
 <label>TABLE 4</label>
 <caption>
  <p>Consensus statements derived from the Delphi process and the level of agreement achieved</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col align="left" span="1"/>
   <col align="center" span="1"/>
   <col align="center" span="1"/>
   <col align="center" span="1"/>
   <col align="center" span="1"/>
   <col align="center" span="1"/>
   <col align="center" span="1"/>
  </colgroup>
  <thead>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>Consensus statement</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">
     <bold>1 (lowest relevance)</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">
     <bold>2</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">
     <bold>3</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">
     <bold>4</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">
     <bold>5 (highest relevance)</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">
     <bold>Mean±
      <sc>sd</sc>
     </bold>
    </td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>1. Large droplets increase the risk of respiratory viral infection through direct transmission.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">15 (40.5)</td>
    <td align="center" rowspan="1" colspan="1">3.9±1.1</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>2. Respiratory viral infections are more likely to occur in older patients (with or without comorbidities) and infants.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
    <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">12 (32.4)</td>
    <td align="center" rowspan="1" colspan="1">9 (24.3)</td>
    <td align="center" rowspan="1" colspan="1">3.6±1.1</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>3. Elderly patients are more likely to develop acute respiratory distress syndrome and there is an age-related death risk.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">23 (62.2)</td>
    <td align="center" rowspan="1" colspan="1">4.5±0.7</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>4. Antibodies might neutralise respiratory viruses and, then, decrease the risk of recurrent infections.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">17 (46.0)</td>
    <td align="center" rowspan="1" colspan="1">9 (24.3)</td>
    <td align="center" rowspan="1" colspan="1">3.8±0.9</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>5. BCG vaccination might offer protection against COVID-19. RCTs are needed.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">3.2±1.2</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>6. Severe COVID-19 is associated with rapid virus replication, massive inflammatory cell infiltration in the lung and elevated pro-inflammatory cytokine/chemokine response.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">29 (78.4)</td>
    <td align="center" rowspan="1" colspan="1">4.8±0.5</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>7. High initial SARS-CoV-2 load in the airways, older age (≥65 years) and comorbidities of the infected individual are associated with worse COVID-19 outcome and thus patients with these risk factors need close attention.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">3 (8.1)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">27 (73.0)</td>
    <td align="center" rowspan="1" colspan="1">4.7±0.6</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>8. The combination of CT scan findings (ground-glass opacity and consolidation), clinical presentation respiratory parameters (
      <italic>S</italic>
      <sub>p</sub>
      <sub>O
       <sub>2</sub>
      </sub> and 
      <italic>P</italic>
      <sub>a</sub>
      <sub>O
       <sub>2</sub>
      </sub>/
      <italic>F</italic>
      <sub>I</sub>
      <sub>O
       <sub>2</sub>
      </sub>) and blood tests (C-reactive proteins, lymphocyte number, fibrinogen, D-dimers, IL-6) helps identifying COVID-19 patients at highest risk for ICU transfer.
     </bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">26 (70.3)</td>
    <td align="center" rowspan="1" colspan="1">4.6±0.6</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>9. CD4 T-cell count is key to guide the aetiological evaluation of lung infections in HIV-infected individuals.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">3 (8.1)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">18 (48.7)</td>
    <td align="center" rowspan="1" colspan="1">9 (24.3)</td>
    <td align="center" rowspan="1" colspan="1">3.9±0.9</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>10. Temporary immunosuppression induced by TB might increase the susceptibility to influenza viruses.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">2 (5.4)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
    <td align="center" rowspan="1" colspan="1">18 (32.5)</td>
    <td align="center" rowspan="1" colspan="1">9 (24.3)</td>
    <td align="center" rowspan="1" colspan="1">3.5±1.2</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>11. An excess mortality associated with influenza is found among TB patients.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
    <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
    <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
    <td align="center" rowspan="1" colspan="1">15 (40.5)</td>
    <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
    <td align="center" rowspan="1" colspan="1">3.7±1.1</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>12. Chloroquine and hydroxychloroquine have potential to improve the treatment success rate of COVID-19 patients. RCTs are needed.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
    <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
    <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
    <td align="center" rowspan="1" colspan="1">9 (24.3)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">3.1±1.3</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>13. Public and social distancing reduce the risk of SARS-CoV-2 transmission.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">3 (8.1)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">28 (75.7)</td>
    <td align="center" rowspan="1" colspan="1">4.7±0.6</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>14. Appropriate use of facial masks (surgical masks in the general population; N95 for HCWs performing aerosol-producing activities) on symptomatic patients and their contacts can reduce the risk of SARS-CoV-2 infection by limiting the spread of droplet nuclei from isolated symptomatic patients.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
    <td align="center" rowspan="1" colspan="1">9 (24.3)</td>
    <td align="center" rowspan="1" colspan="1">27 (73.0)</td>
    <td align="center" rowspan="1" colspan="1">4.7±0.5</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>15. SARS-CoV-2 virus remains infectious in the environment on different surfaces for days.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
    <td align="center" rowspan="1" colspan="1">20 (54.1)</td>
    <td align="center" rowspan="1" colspan="1">4.1±1.1</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>16. Social protection measures and specific national centralised emergency plans can reduce the healthcare and socioeconomic burden of respiratory viral infections resulting in epidemics/pandemics.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
    <td align="center" rowspan="1" colspan="1">14 (37.8)</td>
    <td align="center" rowspan="1" colspan="1">19 (51.4)</td>
    <td align="center" rowspan="1" colspan="1">4.4±0.7</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>17. Stigma and social discrimination affect all virus-infected population groups but disproportionately the minorities.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
    <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
    <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
    <td align="center" rowspan="1" colspan="1">12 (32.4)</td>
    <td align="center" rowspan="1" colspan="1">13 (35.1)</td>
    <td align="center" rowspan="1" colspan="1">3.9±1.1</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <bold>18. Late implementation of national lockdown can itself alone be effective in reducing the burden of COVID-19 but it has serious impact on the society and the economy.</bold>
    </td>
    <td align="center" rowspan="1" colspan="1">3 (8.1)</td>
    <td align="center" rowspan="1" colspan="1">3 (8.1)</td>
    <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
    <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
    <td align="center" rowspan="1" colspan="1">17 (46.0)</td>
    <td align="center" rowspan="1" colspan="1">3.9±1.3</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Data are presented as n (%), unless otherwise stated. BCG: bacille Calmette–Guérin; RCT: randomised controlled trial; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; CT: computed tomography; 
   <italic>S</italic>
   <sub>p</sub>
   <sub>O
    <sub>2</sub>
   </sub>: arterial oxygen saturation measured by pulse oximetry; 
   <italic>P</italic>
   <sub>a</sub>
   <sub>O
    <sub>2</sub>
   </sub>: arterial oxygen tension; 
   <italic>F</italic>
   <sub>I</sub>
   <sub>O
    <sub>2</sub>
   </sub>: inspiratory oxygen fraction; IL: interleukin; ICU: intensive care unit; TB: tuberculosis; HCW: healthcare worker.
  </p>
 </table-wrap-foot>
</table-wrap>
